Figure 5From: Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patientsSimulated cystine median (lines) and IC90 (dashed lines) concentrations (nmol half-cystine/mg of protein) according to bodyweight groups for the usual recommendations and for our dosing scheme (mg/kg/day) administrated either in QID regimen or TID regimen.Back to article page